| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/04/2006 | US20060093676 Ascorbic acid stability |
| 05/04/2006 | US20060093675 Intravaginal treatment of vaginal infections with metronidazole compositions |
| 05/04/2006 | US20060093674 Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof |
| 05/04/2006 | US20060093673 Controlled release of anti-arrhythmic agents |
| 05/04/2006 | US20060093672 Biodegradable oxidized cellulose esters |
| 05/04/2006 | US20060093671 Galantamine particles that may be in salt form and an excipient, coated by a release rate controlling membrane; alleviates Alzheimer's dementia and related dementias, when used in amounts insufficient to cause adverse effects |
| 05/04/2006 | US20060093670 Sustained-release composition process for producing the same and preparation thereof |
| 05/04/2006 | US20060093669 Calcium hypochlorite blended tablets |
| 05/04/2006 | US20060093668 Melt granulated composition and modified release dosage form prepared from said composition |
| 05/04/2006 | US20060093667 Method for manufacturing a low dose pharmaceutical composition having uniform drug distribution and potency |
| 05/04/2006 | US20060093666 Formulations for tyrosine kinase inhibitors |
| 05/04/2006 | US20060093665 Method to improve surface properties of pharmaceutical tablets |
| 05/04/2006 | US20060093664 soft gelatin capsule comprising alpha-, beta-, delta-, and gamma-forms of tocopherols and tocotrienols; to provide protection of the cell membrane lipid layer, and protection against heart disease, cancer, and eye disease |
| 05/04/2006 | US20060093663 Drug delivery system and drug capsule and transmitter used therefore |
| 05/04/2006 | US20060093662 Liposomal camptothecins and uses thereof |
| 05/04/2006 | US20060093661 Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs |
| 05/04/2006 | US20060093660 Compositions for treatment with glucagon-like peptide, and methods of making and using the same |
| 05/04/2006 | US20060093659 Hydroxide-releasing agents as skin permeation enhancers |
| 05/04/2006 | US20060093656 Warming patch |
| 05/04/2006 | US20060093654 Thin aqueous cataplasm material |
| 05/04/2006 | US20060093653 Periadventitial delivery device |
| 05/04/2006 | US20060093652 Collagen product with an alginate sheath and method for producing the same |
| 05/04/2006 | US20060093636 Allantoin-containing skin cream |
| 05/04/2006 | US20060093631 Dye-free pharmaceutical suspensions and related methods |
| 05/04/2006 | US20060093630 Dye-free pharmaceutical suspensions and related methods |
| 05/04/2006 | US20060093629 Dye-free pharmaceutical suspensions and related methods |
| 05/04/2006 | US20060093627 Method of protecting chronic infections |
| 05/04/2006 | US20060093619 Medicament for prevention and treatment of bone fracture and osteoporosis |
| 05/04/2006 | US20060093613 Soluble T cell receptor |
| 05/04/2006 | US20060093598 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 05/04/2006 | US20060093576 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 05/04/2006 | US20060093560 Immediate release film coating |
| 05/04/2006 | US20060093559 Chewing gum composition with vegetal additives |
| 05/04/2006 | US20060093557 Particulate composition |
| 05/04/2006 | US20060093556 Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
| 05/04/2006 | US20060090766 Surface modified viscoelastics for ocular surgery |
| 05/04/2006 | DE20023802U1 Spritzgegossener wasserlöslicher Behälter An injection molded water-soluble container |
| 05/04/2006 | DE20023801U1 Spritzgegossener wasserlöslicher Behälter An injection molded water-soluble container |
| 05/04/2006 | DE19758100B4 Verfahren zum Herstellen von Pflanzenextrakt enthaltenden pharmazeutischen Formulierungen A method for producing pharmaceutical formulations containing plant extract |
| 05/04/2006 | DE102004053373A1 Erfindung betreffend anisometrische Partikel in Form von Nano-/Meso-Fasern -Röhren, -Kabeln -Bändern und deren gekrümmte oder verzweigte Abwandlungen Invention relating anisometric particles in the form of nano / meso-fibers Tubes, CABLES tapes and their curved or branched modifications |
| 05/04/2006 | DE102004052533A1 Particles for use in diagnosis and therapy, especially for binding therapeutic agent for treating e.g. tumors and bacterial, rheumatic, neurologic and thrombotic diseases, have nanocrystalline magnetic core and envelope enclosing core |
| 05/04/2006 | CA2587199A1 Dosage forms having a microreliefed surface and methods and apparatus for their production |
| 05/04/2006 | CA2587169A1 Dosage forms having a microreliefed surface and methods and apparatus for their production |
| 05/04/2006 | CA2587104A1 Dosage forms having a microreliefed surface and methods and apparatus for their production |
| 05/04/2006 | CA2587087A1 Dosage forms having a microreliefed surface and methods and apparatus for their production |
| 05/04/2006 | CA2587082A1 Dosage forms having a microreliefed surface and methods and apparatus for their production |
| 05/04/2006 | CA2587046A1 Dosage forms having a microreliefed surface and methods and apparatus for their production |
| 05/04/2006 | CA2585836A1 Process for forming amorphous atorvastatin |
| 05/04/2006 | CA2585444A1 Dosage forms having a microreliefed surface and methods and apparatus for their production |
| 05/04/2006 | CA2585426A1 A highly porous, fast-disintegrating solid dosage form and its way of manufacturing comprising the preparation of a powder and a freezedrying step |
| 05/04/2006 | CA2584957A1 Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
| 05/04/2006 | CA2584547A1 Solid pharmaceutical composition comprising donepezil hydrochloride |
| 05/04/2006 | CA2584469A1 Burst-release polymer composition and dosage forms comprising the same |
| 05/04/2006 | CA2584122A1 Loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same |
| 05/04/2006 | CA2583756A1 Pharmaceutical composition comprising microcapusles of statins suspended in alkyl esters of polyunsaturated fatty acids (pufa) |
| 05/04/2006 | CA2583642A1 Transdermal delivery systems |
| 05/04/2006 | CA2577862A1 Pharmaceutical composition comprising diclofenac |
| 05/04/2006 | CA2525204A1 Patch containing a substances selected from tars having reducing characteristics in dermatology |
| 05/03/2006 | EP1652914A1 Virosome particles comprising antigens from influenza virus and Hepatitis B virus |
| 05/03/2006 | EP1652545A1 Surface for contact with human, animal or artificial tissue |
| 05/03/2006 | EP1652539A1 Method of manufacturing a stent comprising an anti-angiogenic composition |
| 05/03/2006 | EP1652535A1 Semi-solid mucoadhesive formulations |
| 05/03/2006 | EP1652534A2 Composition comprising coagulation factor VIII formulation, process for its preparation and use of a surfactant as stabilizer |
| 05/03/2006 | EP1652528A1 Activated carbon infusion solution, preparation method therefor and use thereof for the manufacture of drug for treating cancer |
| 05/03/2006 | EP1652524A1 Dry syrup containing loratadine |
| 05/03/2006 | EP1652523A1 Transdermal absorption preparation |
| 05/03/2006 | EP1652522A1 Sustained release tablet for oral use |
| 05/03/2006 | EP1652518A1 Pharmaceutical composition for sublingual administration |
| 05/03/2006 | EP1652517A1 Hyaluronic acid nanoparticles |
| 05/03/2006 | EP1652515A1 Process for producing drug ultramicroparticle and apparatus therefor |
| 05/03/2006 | EP1652514A1 At-use dispersed preparation |
| 05/03/2006 | EP1652513A1 Reverse micelles based on sterols and acylglycerols and therapeutic uses thereof |
| 05/03/2006 | EP1652512A1 Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation |
| 05/03/2006 | EP1652508A1 Adhesive patch |
| 05/03/2006 | EP1651706A1 Coated water-swellable material |
| 05/03/2006 | EP1651566A1 Highly oil absorbing amorphous silica particles |
| 05/03/2006 | EP1651275A1 Use of recombinant or synthetic gelatin-like proteins as stabiliser in lyophilized pharmaceutical compositions |
| 05/03/2006 | EP1651274A1 Bioadhesive gel based on hydroxyethylcellulose |
| 05/03/2006 | EP1651273A1 Poly-4-hydroxybutyrate matrices for sustained drug delivery |
| 05/03/2006 | EP1651270A1 Medicaments for inhalation comprising betamimetics and an anticholinergic |
| 05/03/2006 | EP1651255A1 Topical veterinary compositions and methods for the treatment and prevention of infection |
| 05/03/2006 | EP1651249A1 Use of calcitonin in osteoarthritis |
| 05/03/2006 | EP1651248A1 Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form |
| 05/03/2006 | EP1651236A1 Combination of an anticholinergic and a steroid and its use to treat respiratory disorders by inhalation |
| 05/03/2006 | EP1651233A2 Pharmaceutical composition |
| 05/03/2006 | EP1651230A1 Medicaments for inhalation comprising steroids and a novel anticholinergic |
| 05/03/2006 | EP1651221A1 Medicaments for inhalation comprising betamimetics and an anticholinergic agent |
| 05/03/2006 | EP1651218A1 Fexofenadine composition and process for preparing |
| 05/03/2006 | EP1651216A2 Infection prophylaxis using immune response modifier compounds |
| 05/03/2006 | EP1651215A1 Transdermaltherapeutic system containing a pramipexol active agent |
| 05/03/2006 | EP1651210A1 Dispersible formulation of an anti-inflammatory agent |
| 05/03/2006 | EP1651208A1 Medicaments comprising pde iv inhibitors and a novel anticholinergic and their use for treating respiratory disorders |
| 05/03/2006 | EP1651204A1 Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator |
| 05/03/2006 | EP1651202A1 Compositions containing prodrugs of florfenicol and methods of use |
| 05/03/2006 | EP1651200A1 Polyhydroxy phenols and their use in bindng p-selectin |
| 05/03/2006 | EP1651197A1 Transdermal warfarin-containing delivery system |
| 05/03/2006 | EP1651196A2 Tamper-resistant transdermal dosage form comprising an active component and an adverse agent component and an adverse agent component at the distal site of the active agent layer |
| 05/03/2006 | EP1651195A2 Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease |
| 05/03/2006 | EP1651194A1 Stable controlled release pharmaceutical compositions containing fenofibrate and pravastatin |
| 05/03/2006 | EP1651193A2 Pharmaceutical compositions having a swellable coating |